CLINICAL_TRIALS ClinicalTrials.gov record update

Double Blind Randomized Controlled Trial of Recombinant Human Platelet Derived Growth Factor-BB Gel (Regranex Gel®) Versus Hydrogel (Duoderm Hydrogel®) for Healing of MARTORELL's Hypertensive Leg Ulcers. ERAN Trial.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00970697
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:07.846806+00:00
Published At: 2011-10-04T00:00:00+00:00
Record Updated At: 2011-10-04
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["MARTORELL\u0027S ULCER", "Hypertensive Leg Ulcer", "Necrotic Angiodermatitis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2011-10-04"
protocolSection.identificationModule.nctId: "NCT00970697"
protocolSection.identificationModule.officialTitle: "Double Blind Randomized Controlled Trial of Recombinant Human Platelet Derived Growth Factor-BB Gel (Regranex Gel\u00ae) Versus Hydrogel (Duoderm Hydrogel\u00ae) for Healing of MARTORELL\u0027s Hypertensive Leg Ulcers. ERAN Trial."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.